ACADIA Pharmaceuticals Announces Senior Management Appointments in Manufacturing, Quality, Compliance, Access and Reimbursement and Business Development

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/7/2026

1. SPCX
2. CRNX
3. USO
4. VRTX
5. SPY
6. WMT
7. RXST
8. RIVN
9. NVDA
10. LMT

Go back to ACADIA Pharmaceuticals Announces Senior Management Appointments in Manufacturing, Quality, Compliance, Access and Reimbursement and Business Development

Cowen Raises Price Target on Acadia Pharma (ACAD) Following 2Q15

August 7, 2015 6:56 AM EDT

Cowen reiterated an Outperform rating on Acadia Pharmaceuticals (NASDAQ: ACAD), and raised the price target to $50.00 (from $43.00), following 2Q15 results. ACAD reported 2Q15 EPS of $(0.39) vs consensus of $(0.33).

Analyst Ritu Baral commented, "ACAD's 2Q15 call was largely uneventful with ACAD... More